AAV Purification: Ultracentrifugation vs. Chromatography
Purification is a decisive step in AAV quality. Density-gradient ultracentrifugation is a mature, research-scale method, while chromatography is better suited to scale-up, automation, and GMP manufacture. Neither is universally superior; the right choice depends on production scale, purity requirements, empty-capsid separation, recovery, and downstream application.
IntroductionThere is no single best AAV purification method. Ultracentrifugation and chromatography each have strengths, and the two are often combined in a single process train. The practical decision is driven by scale and by the need for empty-versus-full separation, batch consistency, and process robustness. Final quality, however, is never defined by the purification method alone — it must be confirmed through titer, purity, full/empty ratio, genome integrity, residual DNA and protein, endotoxin, and aggregate testing.
Two Approaches
Understand What Each Method Actually Does
Both methods separate AAV from contaminants using different physical or chemical principles, and each has a distinct role in a purification train.
Method 1 · Ultracentrifugation
Density-gradient ultracentrifugation
Virus particles are separated from impurities by physical differences in density. Iodixanol density gradients are common in research, with CsCl gradients as an alternative. Established gradients can remove a substantial share of protein, nucleic acid, and other impurities, and can achieve a degree of empty/full separation because empty and full capsids differ in density. The outcome depends on serotype, empty-capsid fraction, gradient design, and collection technique.
Fit: small-to-medium research lots where convenience matters more than scale.
Method 2 · Chromatography
Affinity and ion-exchange chromatography
Chromatography separates AAV by affinity or charge differences. Affinity capture uses capsid-ligand interactions to pull AAV from a complex feed, while ion-exchange polish exploits charge differences for finer separation, including empty/full resolution in some modes. Multi-step chromatography trains typically combine capture, purification, and polishing into a scalable, automatable process.
Fit: medium-to-large scale and GMP processes requiring standardization and reproducibility.
Method Families
Sub-Methods Within Each Approach
Within ultracentrifugation and chromatography there are distinct sub-methods, each with a specific principle and role in a purification train.
Sub-method
Principle
Primary role
Key caveats
Iodixanol gradient
Density separation under ultracentrifugation
Research-scale purification with partial empty/full separation
Operator-dependent, low throughput, and difficult to scale.
CsCl gradient
Density separation at high ionic strength
High-purity research preparation
Time-intensive; residual CsCl must be removed; can stress capsids.
Affinity chromatography
Capsid–ligand capture (e.g., AVB, CaptureSelect)
Capture from complex feed
Limited empty/full resolution; ligand and serotype considerations.
Anion-exchange (AEX)
Charge-based separation
Polish and empty/full separation
Empty/full peaks can overlap; method is serotype-specific.
Cation-exchange / multimodal
Charge or mixed-mode interactions
Polish, aggregate removal, and orthogonal separation
Serotype-dependent binding and elution behavior.
Head-to-Head
How the Two Methods Differ
The differences are practical, not philosophical. They shape which method a program should standardize on as it moves from research toward manufacturing.
Dimension
Ultracentrifugation
Chromatography
Production scale
Well suited to laboratory and research scale; equipment capacity and rotor limits constrain scale-up.
Suited to medium-to-large scale; column and membrane systems scale by design.
Standardization
Results depend on gradient preparation, conditions, and operator skill.
Loading, wash, and elution parameters are systematically controlled and automated.
Empty/full separation
Can separate empty and full capsids to a degree via density differences.
Varies by mode: affinity capture has limited empty/full resolution, while ion exchange provides finer separation.
Scalability
Limited by device, rotor, and manual operation.
Adjustable via column volume, membrane area, and system parameters.
Batch consistency
Can vary between batches due to manual handling.
Easier batch-to-batch consistency through automated control of key parameters.
Equipment & throughput
Requires dedicated ultracentrifuges and rotors; low throughput and manual operation.
Runs on scalable chromatography systems with higher throughput and automation.
Typical use
Research-grade and small in-process preparations.
Process development, scale-up, and GMP manufacture.
Process Train
Build a Multi-Step Purification Sequence
A robust process combines steps rather than relying on a single method, so that each unit operation addresses a specific purification objective.
Step 1 · Clarification
Remove cells and large debris
Clarification and nuclease treatment reduce host-cell nucleic acid and prepare the feed for downstream steps, lowering viscosity and column fouling.
Objective: a clean, filterable feed for capture.
Step 2 · Capture
Concentrate the product
Affinity chromatography (or density-gradient ultracentrifugation at research scale) captures AAV from a complex feed and removes the bulk of process impurities.
Objective: high product recovery with major impurity reduction.
Step 3 · Polish
Refine purity and empty/full ratio
Ion-exchange or multimodal chromatography removes remaining protein, nucleic acid, and reagent residuals, and can separate empty from full capsids.
Objective: meet purity and empty-capsid specifications.
Step 4 · Formulation
Concentrate and exchange buffer
Concentration and buffer exchange into the final formulation prepare the product for storage, dosing, and stability.
Objective: a stable, injectable final product.
Selection Framework
Choose by Scale and by What Must Be Controlled
The choice is best made by application rather than by absolute preference, and the two methods can be combined into a single process train.
01
Research Scale
For small, research-grade lots, ultracentrifugation — especially iodixanol gradients — is practical and mature.
02
Mid-to-Large Scale
For larger batches, chromatography offers the scalability and automation required for reproducible production.
03
GMP Manufacture
Chromatography is usually the core platform, typically as a multi-step, quality-controlled process rather than a single method.
04
Combined Trains
The two are not mutually exclusive: pre-treatment, capture, polish, and concentration can mix centrifugation and chromatography.
05
Balance Recovery
Higher purity is not automatically better if yield, integrity, or stability suffers.
06
Confirm Quality
Validate with titer, purity, full/empty ratio, residuals, endotoxin, and aggregate data.
Beyond the Method
Four Quality Attributes That Define the Final Product
The purification method is only the starting point. Product quality must be confirmed by measurement.
TITER
Genome and capsid titer
Confirm the quantity of packaged genomes and total capsids after purification, since yield and concentration change through the process.
FULL/EMPTY
Empty-capsid ratio
Empty capsids affect dose and immunity; the purification train should reduce them to an acceptable, defined level.
RESIDUALS
Residual DNA and protein
Host-cell DNA, host-cell protein, and reagent residuals must be controlled to the lowest achievable level.
SAFETY
Endotoxin and aggregates
Endotoxin, sterility, and aggregate content complete the safety and stability picture for the purified product.
Project Support
Creative Biolabs Support
Creative Biolabs provides linked AAV purification and characterization capabilities that can be scoped around your scale, purity, and empty-capsid requirements.
European Medicines Agency. Quality, non-clinical and clinical issues relating specifically to recombinant adeno-associated viral vectors. Scientific guideline.
Purification, characterization and lyophilization of adeno-associated virus vectors. Reviewed as source material for AAV purification method selection, purity, and empty-capsid analysis.
ICH Q5A(R2). Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin.
Neither is universally better. Ultracentrifugation is practical for small research-scale lots and offers a degree of empty/full separation, while chromatography is more scalable, automatable, and standardized, making it the usual choice for medium-to-large scale and GMP manufacture. The two are often combined in a single process train.
Yes. A process train can mix pre-treatment, capture, polish, and concentration steps using either technique. Research projects often use density-gradient ultracentrifugation followed by concentration and buffer exchange, while larger processes center on multi-step chromatography.
Not necessarily. Empty/full separation depends on the mode. Affinity chromatography is mainly a capture step with limited empty/full resolution, while ion-exchange chromatography provides finer separation. Density-gradient ultracentrifugation can also separate empty from full capsids. The right choice depends on the specific product and process.
Consider production scale, purity requirements, empty-capsid ratio targets, recovery and integrity, and the downstream application. Higher purity is not automatically better if it sacrifices yield or stability, so the method must balance these objectives.
No. Final quality must be confirmed by measuring titer, purity, full/empty ratio, genome integrity, residual DNA and protein, endotoxin, and aggregates. The purification method is one input into that overall quality picture.
Affinity chromatography is primarily a capture step. It uses capsid–ligand interactions to pull AAV out of a complex feed and remove the bulk of impurities. It has limited empty/full resolution, so a polish step such as ion exchange is typically added downstream.
Ion exchange separates particles by surface charge. Because empty and full capsids have different isoelectric points, anion exchange can resolve them, with empty capsids eluting before full capsids. The separation is serotype-specific and the peaks can overlap, so some full capsids may be sacrificed to remove empty.
A common train is clarification and nuclease treatment, followed by capture (affinity chromatography or ultracentrifugation), polish (ion-exchange or multimodal chromatography), and finally concentration and buffer exchange into the final formulation.
Design a Purification Strategy Matched to Your Scale
Share your serotype, production scale, purity and empty-capsid targets, and downstream application. Creative Biolabs can help define a purification approach that balances purity, recovery, and consistency.
